Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001193125-25-326775

President and CEO gave up 367,497 shares (to pay taxes)

  • President and CEO acquired 1,025,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Robbins Andrew R · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-17 Grant or award : show line 1 in the form +185,000 185,000 D
2025-12-17 Grant or award : show line 2 in the form +840,000 1,025,000 D
2025-12-17 Shares withheld for taxes : show line 3 in the form −367,497 $39.45 $14,497,757 657,503 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-17 Grant or award : show line 4 in the form Stock Option (Right to Buy) +245,000 245,000 D
Loading xslF345X05/ownership.xml…